Monoclonal Antibodies Flashcards

1
Q

What is the difference between Mono and Polyclonal Abs, and what does Polyclonal Ab require for production?

A

-Polyclonal Abs are produced by multiple immune cells –> bind to many epitopes on an antigen, monoclonal Abs are produced by identical immune cells (clones from the parent cell) binding to a single epitope

-Production of polyclonal Abs require live-animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Advantages and Disadvantages of Polyclonal Abs

A

Advantage: bind to multiple epitopes -> highly effective in neutralizing antigens or toxins

Disadvantages: immunogenicity, serum sickness, antibodies may vary from batch to batch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical uses of polyclonal antibodies?

A

-passive immunization
-post-exposure to toxins or virus -> to neutralize toxins or virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the difficulties a patient might suffer from multiple polyclonal treatments?

A

-Serum sickness
-Deposition of immun-complexes in joints -> Pain
-in severe cases: Anaphylactic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the purpose of the hybridoma technique?

A

-creating immortal monoclonal antibody-producing cells
-by fusing B-cells from the spleen (from mouse, producing Abs) and cancer cells (human myeloma, immortal) –> Hybridoma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why was PEG used in the hybridoma technique?

A

Becuase of the solvent property, binding to lipid membrans
-it fuses B-cell and myeloma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the purpose of the selection HAT medium?

A

-To separate the preferred hybridoma cells from unhybridized B-cells and cancer cells

-the cancer cells carry a mutation for Thymidine kinase, so they cant use the salvage pathway to survive + HAT medium contains aminopterin (antimetabolite) preventing the cancer cells to use the de novo pathway –> cancer cells die in the HAT media

-B-cells are mortal and die after some cell cycles

ONLY HYBRIDOMA cells survive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why do only Hybridoma cells survive in the HAT medium?

A

Because they are hybrids
-gained the ability to use the thymidine kinase from B-cells to use the Salvage pathway
-gained immortality from cancer cells

->even though the HAT media blocks the de novo pathway, they survive by using the Salvage pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How to check if the hybridoma technique worked?
Selection for hybridoma positive cells

A

-Grow the cells on Selection HAT medium and on Screening plates (ELISA) containing antigens that are specific for the produced antibodies

-> Only hybridoma cells will stick to the antigens -> These cells can be recultured and produce multiple monoclonal antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the advantages of using hybridoma cells instead of live animals to produce antibodies?

A

-hybridoma cells are immortal and can keep on producing endless amounts of Abs

-constant amounts of Abs
-> live-animals will have variability because they might not produce the same amounts depending on the conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the disadvantages of using hybridoma cells?

A

-they are murine (mouse-origin) -> can be immunogenic
-antibodies can only be tested against one antigenic protein per clone
-it is a slow process, takes time to find the Ab that really works for an antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does the Phage expression system work?

A

-creating predominantly human antibodies

  1. multiple human antigen-binding fragment genes (Fab) were expressed in a phage (virus) -> the human Fabs were expressed in the viral coat
  2. the viruses that contain the human Fab of interest were reproduced in E-coli to generate a large number of predominantly human antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is the Phage expression system useful?

A

-many different monoclonal Ab can be created and screened at once

-it predominantly produces human antibodies (the Fab part is human, the Fc region might be from an animal) with lower immunogenic response in patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which drug was first approved using the Phage expression system?

A

Adalimumab (HUMIRA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is a Xenomouse used to produce human monoclonal Abs?

A

-using Knockout mice
-Deactivation of the mouse gene for Ab -> insertion of human Ab heavy and light chain genes
-the mouse produces human antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which Immunoglobin Isotpe is mostly used for therapeutic use?

A

IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which part of the Antibody can contain Glycolysation?

A

The Fc region

18
Q

Why are most of the Antibodies soluble?

A

Because of Glycolysation on the Fc region of the Ab

19
Q

Which region of the Ab is involved in Ag binding?

A

CDR = complementary determining region on the Variable part of the light and heavy chain
-highly variable, and adaptable binding to different antigens

20
Q

What is the meaning of a bivalent IgG antibody?

A

An IgG antibody can bind to 2 identical antigens (same antigen)

21
Q

What are functions of the Fc region?

A

-can be Glycolyzed
-provides a longer half-life compared to Ab lacking the Fc region
-it binds to Fc-γ receptors on NK cells to mediate the killing of an infected cell (ADCC - Antibody-dependent cellular cytotoxicity)
-complement-fixation (killing by complement system)

22
Q

Nomenclature of monoclonal antibodies
EXAM !!!

A

Mouse (o): 0% human - momab
Chimeric (xi): 60% human - ximab
Humanized (zu): 90% human only CDR is animal - zumab
Fully Human (u): 100% human from Xenomouse - umab

23
Q

Advantages of whole monoclonal Abs

A

-highly specific -> minimal off-target effects
-human mAB have little immunogenicity

-Fc fragment help attract immune cells/complement fixation
-Fc fragment prolongs half-life
-Fc fragment contains glycosylation -> increase solubility

24
Q

Disadvantages of monoclonal Abs

A

-monospecific (bind to only 1 type of Ag)
-binding to more than 2 Ag is not possible (not bivalent)
-Extensive glycosylation make production complex (f.e. Ecoli cant make PTMs)
-hard to penetrate tissues bc of the large size

25
Q

What are strategies to overcome the disadvantages of whole antibodies?

A

-create Antibody fragments (ScFv) or derivatives
less complex and cheaper
can be engineered to bind multiple epitopes
better penetration of tissues

BUT: lack of Fc portion reduces the half-life

26
Q

What are the difficulties of lacking the Fc portion?

A

-lower short-life
-no cell-mediated immunity bc Fc region binds to Fc-γ on NK cells

27
Q

What is an example of a drug using fragmented Antibodies?

A

-Anti-VEGF treatment (treating increased amounts of blood vessels to reduce pressure on the retina)
-Ranibizumab (Lucentis)

28
Q

Why is the short half-life due to the lack of the Fc region, not a big deal in the VEGF treatment?

A

Because it is administered locally on the eye and the drug doesn’t need a long half-life

29
Q

Where does the Antibody Ranibizumab originate?

A

zumab –> 90% human

30
Q

What is the function of BiTE Antibodies?

A

-BiTE: Bispecific T-cell engager - Blinatumomab (Blincyto)
-Two Ag binding domains (CD3 on T cells and CD19 on leukemia cells) connected with a peptide linker
-guides T cells to leukemia cells (Acute Lymphoblastic Leukemia ALL often in children)

31
Q

Purpose of Fc fusion proteins:

A

The same IgG Fc region can be fused to different ligands of interest
-f.e. Abatacept blocking T cells from binding with APC cells
-> for Autoimmune diseases like Rheumatoid Arthritis

32
Q

What is a method to extend the half-life of fragmented Ab?

A

PEGylation (wrapped around)
-more soluble bc of Polyethylene glycol
-reduces Anti-drug-Antibody response
-Example: Certolizumab (Cimzia)

33
Q

Therapeutic uses of monoclonal Abs

A

-Neutralization (TNF in autoimmune diseases, anti-VEGF)
-Trigger cell-mediated cell death by NK cells (Fc region binds to Fc-γ of NK cells)
-Checkpoint inhibition (signal that marks the cell as self to prevent it from being eliminated; cancer cells misuse that)

-Radioimmunotherapy: Ab tagged to radioactive agents -> Ab targets specific tissues in cancer treatment
-Radio imaging: imaging in diagnostics

34
Q

How can antibodies be used against TNF (inflammatory mediators) or IgE-mediated inflammation?

A

Direct neutralization with anti-TNF antibodies in Autoimmune diseases or blocking IgE with anti-IgE antibodies (Omalizumab (Xolair) in Allergies

35
Q

What is the function of checkpoint inhibitors?

A

-Checkpoints prevent self-cells from being killed by the immune system
-cancer cells create checkpoint receptor (PD-1, PDL-1) to indicate that they are self-cells to the immune system
-cancer drugs like Nivolumab (antibodies) block these checkpoint receptors

36
Q

When are anti-cancer drugs targeting overexpressed antigens most effective?

A

When the cancer cell expresses the targeted antigen constantly and is not subject to phenotype changes

-Due to mutations cancer cells change their phenotype and rate of expression by the time an Ab is created

37
Q

How can cancer cells that produce specific antigens be targeted with monoclonal antibodies?

A

With monoclonal antibodies linked with cytotoxic drugs
-the antibody will bind to the antigens produced by the cancer cell and release the cytotoxic drug

38
Q

Different therapeutic mechanisms and examples:

A

-ADCC and CDC-mediator: Rituximab (Rituxan)
-Checkpoint inhibitors: Nivolumab (Anti PD-L1)
-Cytotoxic-linked Antibodies: Trastuzumab (Ab) linked to DM1 (anti-mitotic) –> Antibody linked Conjugate (ADC) -> binds HER2 receptors on breast cancer cells

-Radioimmunotherapy: Ibritumomab (Zavelin) tagged to a beta-emitter (radioactive) binds to CD20 on cancer B-cells
-Radioimaging: rhenium-186-labeled antibody (c-mAb) U36

39
Q

Antibodies and indications

A

-Adalimumab (Humira) for Crohn’s and RA (monoclonal)
-Ranibizumab (Lucentis, fragment) + Bevacizumab (Avastin, whole IgG) for Anti-VEGF therapies (local)

-Blinatumomab (Blincyto) for Bispecific T-cell engager (BiTE)
-Abatacept (Orencia) Fc fusion proteins blocking APC - Tcell interaction
-Certolizumab (Cimzia) -> PEGylated small fragments
-Omalizumab (Xolair) direct neutralization of IgE

40
Q

How are Radionuclide-tagged mAb used for imaging?

A

Attach a radionucleotide to an antibody and the antibody will bind and mark specific tissue to make it visible

-rhenium-186-labeled chimeric monoclonal antibody (c-mAb) U36